BEAM THERAPEUTICS INC (BEAM:NASDAQ)
$23.79 -0.26 (-1.0811%)
Analysed BEAM THERAPEUTICS INC (BEAM:NASDAQ) News Sources
Beam Therapeutics Targets Accelerated FDA Approval for Base-Editing Treatment
08-09-2026
yahoo.com
Beam Therapeutics (BEAM) Restored AAT Levels. Can BEAM-302 Deliver Clinical Benefit?
10-09-2026
yahoo.com
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
22-09-2026
stocktwits.com
Beam Therapeutics (BEAM) Stock Could Trade At A Premium As Gene Editing Interest Grows
24-09-2026
yahoo.com
Anthropic AI Discovery Gene-Editing Stocks Falling
24-09-2026
yahoo.com
As Claude Enters the Gene-Editing Arena, There’s Still a Long-Term Case for BEAM Stock
28-09-2026
barchart.com
Beam sues 2 biotechs, alleging theft of base editing trade secrets
29-09-2026
biopharmadive.com
Will IP Theft Allegations Against YolTech and Serapha Bio Change Beam Therapeutics' (BEAM) Narrative
01-10-2026
yahoo.com
Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual Congress
13-10-2026
yahoo.com
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
18-10-2026
fool.com
What is the current price of BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The current price of BEAM THERAPEUTICS INC (BEAM:NASDAQ) is $23.79.
BEAM THERAPEUTICS INC (BEAM:NASDAQ) absolute price change since previous trading day?
The absolute price change of BEAM THERAPEUTICS INC (BEAM:NASDAQ) since the previous trading day is $-0.26.
BEAM THERAPEUTICS INC (BEAM:NASDAQ) percentage price change since previous trading day?
The percentage price change of BEAM THERAPEUTICS INC (BEAM:NASDAQ) since the previous trading day is -1.0811%.
What is the most recent average sentiment score for BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The most recent average sentiment score for BEAM THERAPEUTICS INC (BEAM:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for BEAM THERAPEUTICS INC (BEAM:NASDAQ)?
The most recent sentiment for BEAM THERAPEUTICS INC (BEAM:NASDAQ) is .
SEC-8K** Filing Available For BEAM THERAPEUTICS INC (BEAM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.